You are here

Revlimid

Cramer Finds Catalyst for Celgene’s Stock

CNBC

Wed, 11/4/09 - 08:43 am

Not 50% Growth, but We'll Take It (Celgene)

Motley Fool

Sat, 10/24/09 - 10:45 am

Analysts downgrades Celgene due to higher price and questions about expectations for Revlimid

Yahoo/AP

Thu, 08/6/09 - 01:45 pm

Celgene Corp.: Why This Biotech Drugmaker Is Turning Heads

Seeking Alpha

Thu, 07/30/09 - 09:03 am

Celgene asks for Japanese regulatory approval of Revlimid as secondary cancer treatment

Yahoo/AP

Tue, 07/7/09 - 10:24 am

Celgene Corporation: Take the Money and Run

Seeking Alpha

Tue, 03/3/09 - 11:46 am

NICE deal, Celegene

InVivo

Tue, 02/10/09 - 08:27 am

Celgene's Healthy Outlook

Yahoo/Zacks.com

Fri, 01/2/09 - 10:52 am

Pages